Biocon Biologics announces New Dermatology data to be presented at EADV Congress 2024 Written By Ruchika Sharma25 Sept 2024 2:48 PM ISTBengaluru: Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd has announced new dermatology data presented at the European Academy of...
USFDA concludes inspection at Biocon Bengaluru API facility Written By Ruchika Sharma23 Sept 2024 12:06 PM ISTBangalore: Biocon has announced that the U.S. Food and Drug Administration (US FDA) has concluded a surveillance inspection at the Company's...
Kiran Mazumdar-Shaw calls for innovation-driven value creation in India's biotech sector Written By MD Bureau Team13 Sept 2024 3:13 PM ISTNew Delhi: Biocon Chairperson Kiran Mazumdar-Shaw on Thursday called for more investment in research and development to drive innovation and...
Biocon arm gets USFDA nod for chronic heart failure drug Sacubitril/Valsartan Written By Ruchika Sharma2 Sept 2024 11:27 AM ISTBangalore: Biocon has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received approval of its...
Biocon gets USFDA EIR for Visakhapatnam API facility Written By Ruchika Sharma6 Aug 2024 11:33 AM ISTBangalore: Biocon has announced that the Company has received an Establishment Inspection Report (EIR) with Voluntary Action Indicated...
USFDA concludes inspection at Biocon Biologics Bengaluru facilities Written By Ruchika Sharma29 July 2024 12:53 PM ISTBengaluru: The U.S. Food and Drug Administration (USFDA) has concluded a combined cGMP inspection and PreLicensing Inspection (PLI) at...
Biocon Biologics plans to raise Rs 4,000-4,500 crore via local bonds: Report Ruchika Sharma8 July 2024 12:30 PM ISTBiocon Biologics Ltd., a biopharmaceutical company, is considering raising between Rs 4,000 crore and Rs 4,500 crore from India’s local-currency bond...
USFDA inspection: Biocon gets 4 observations for Visakhapatnam API facility Written By Ruchika Sharma24 Jun 2024 2:15 PM ISTBangalore: Biocon has informed in a BSE filing that the U.S. Food and Drug Administration (USFDA) has concluded a GMP inspection of the...
Biocon arm receives EMA approval to manufacture biosimilar Bevacizumab at Bengaluru facility Written By Ruchika Sharma24 Jun 2024 12:15 PM ISTBengaluru: Biocon Biologics Ltd, a global, fully integrated biosimilars company and a subsidiary of Biocon Ltd, has received approval from the...
Biocon quest for partner in China to test generic versions of Novo Nordisk Wegovy, Ozempic Written By Ruchika Sharma21 Jun 2024 3:56 PM ISTShanghai: Biocon is looking for a partner in China to test generic versions of Novo Nordisk's weight loss treatment Wegovy and diabetes...
USFDA issues 3 observations for Biocon Visakhapatnam API facility Written By Ruchika Sharma16 Jun 2024 11:00 AM ISTBangalore: Biocon has informed in a BSE filing that the U.S. Food and Drug Administration (USFDA) has concluded...
Biocon appoints Mukesh Kamath as Interim CFO, Key Managerial Personnel Ruchika Sharma13 Jun 2024 4:09 PM ISTBangalore: Biocon has announced the appointment of Mukesh Kamath, Head - Business Finance R&D, as the Interim Chief Financial Officer and Key...
